Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trials of New Chemopreventive Agents-25434001
University. of Wisconsin System
Search grants from University. of Wisconsin System
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of Oncostatin-M in Pneumonia
Dopaminergic modulation of frontostriatal function
Social Construction of Benefit in Gene Transfer Research
Cell/Matrix Interactions in Corneal Stromal Development
Gastrointestinal Hormones in Gastrointestinal Cancer
Recently added grants:
Molecular Mechanisms of HFpEF-associated Atrial Fibrillation
Targeting vulnerabilities of PPM1D-mutant gliomas
Tracing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
Regulation of inner ear development by FGF signals and effectors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA034001-005
Application #
6688639
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University. of Wisconsin System
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase II Clinical Trials of New Chemopreventive Agents-25434001
/ University. of Wisconsin System
NIH 2002
N01 CA
Phase II Clinical Trials of New Chemopreventive Agents-25434001
/ University. of Wisconsin System
Comments
Be the first to comment on this grant